How to keep a co-investor's confidentiality promise intact: a twelve-item disclosure boundary checklist that tags every fact by where you learned it and whose promise it would break on the way to SourceX

Short answer

Treat whatever a co-investor told you about a company as information still bound by the co-investor's promise to that company, not as yours to pass on. Before a SourceX introduction, tag each fact by where you learned it. Public facts, and what the CEO tells you directly, can travel once the CEO agrees to be introduced. Anything that reached you through the co-investor, its board seat or its diligence stays behind unless the co-investor and the CEO both say otherwise.

Visual briefFull-size diagram
A hub-and-spoke diagram with your fund at the center, where SourceX updates stay. One ask with public facts goes to the CEO; after her yes only her own words go to SourceX; the co-investor gets no SourceX updates and hears news via the CEO; board packs and diligence memos go nowhere.
The four destinations follow the checklist on this page; no real funds or companies are shown.

Co-investors talk. A syndicate call, an observer's aside after a board meeting, a forwarded deck: a VC ecosystem lead hears plenty about companies their own fund has never been given. The checklist below sorts that knowledge before any of it lands in an introduction.

Three promises sit on one introduction

A data introduction between funds touches three separate confidentiality promises, plus one permission that is not a promise at all.

PromiseMade by, to whomWhere it is usually writtenWhat a careless referral breaks
Confidentiality to the companyThe co-investor, to the companyA confidential disclosure agreement, investor rights terms, a side letterUsing the company's non-public facts for a purpose they were not shared for
Discretion between investorsThe co-investor and you, to each otherA syndicate email, a deal-sharing understanding, sometimes nothing writtenBuilding your own ask on what the co-investor said in confidence
Confidentiality under the partner agreementYou and SourceX, to each otherThe SourceX Channel Partner Agreement, section 4Relaying SourceX's non-public updates to the co-investor or the company
The CEO's permission (a gate, not a promise)The CEO, to whoever introducesA dated written yesIntroducing a company whose CEO never agreed

The co-investor's promise follows the information. The NVCA's model confidential disclosure agreement for life science investors confines a receiving investor's use of company information to internal evaluation of a proposed transaction, and lets the investor share it with its own employees and representatives, including co-investors that already have their own agreement with the company (paraphrase). In that model, a fellow investor can hear the information only inside the frame it was given for. Evaluating a data licensing introduction is a different use. Your fund's documents may say something stricter or looser, so read them; the use restriction guide walks through how such clauses are built.

Your own promise to SourceX runs both ways. The partner agreement defines confidential information to include introduction records, buyer identities, requirements and pricing (1.6). Each side may use the other's confidential information only for the referral relationship (4.1) and share it only with employees, professional advisers and service providers who need it and carry equally protective duties (4.2). A co-investor is not on that list. The agreement also gives a partner no authority to share a company's inventory, records, raw data or personal information (4.2), forbids disclosing non-public deal details without written authorization (4.5), and keeps these duties for three years after it ends (5.3), longer for trade secrets. If your fund signed a separate NDA with SourceX, it continues within its own scope (7.8).

The CEO's permission comes before everything. SourceX's screening guidance says introductions made without the decision maker's knowledge are usually not a fit. No amount of careful redaction makes up for a CEO who never agreed to be introduced.

Trace each fact back to where you learned it

Origin decides travel. Before drafting anything, write each fact you would use next to one of four origins:

  1. Public. The company's website, its own announcements, a public filing.
  2. The CEO, to you. Said directly, in a meeting or message you were part of.
  3. The co-investor, in conversation. A call, a dinner, a syndicate thread.
  4. Documents you hold through someone's rights. Board packs, information-rights reports, a data room, a diligence memo.

Facts from origins 1 and 2 can go to SourceX once the CEO agrees to be introduced. Facts from origins 3 and 4 cannot, unless the co-investor agrees and the CEO restates them to you herself. The partner agreement's own exclusions are a useful model of what usually falls outside a confidentiality duty: information that is public without a breach, known before without restriction, developed independently or received lawfully from someone with no duty (4.3). The co-investor's documents will carry their own list, and theirs is the one that binds the co-investor.

The permission and disclosure boundary checklist

Twelve facts a fund typically holds about a company it co-invests in, each with its usual origin, whether it may reach SourceX, whose yes comes first, and the promise at risk if it slips.

#FactUsual originMay it reach SourceX?Whose yes firstPromise at risk if it slips
1Company legal name and websitePublicYes, after the CEO agrees to be introducedThe CEONone, once the CEO agreed
2The CEO's name and emailPublic, or from the CEOYes, after the CEO's yesThe CEODiscretion between investors, if the co-investor supplied the address
3That an introduction is under wayYour own actionOnly among you, the CEO and SourceXThe CEOPartner agreement 4.5 (non-public deal details)
4Full-time headcount at its peakThe CEO, or publicAs the CEO states itThe CEOCompany confidentiality, if taken from a board pack
5Years of records, systems and record typesThe CEOAs metadata, in the CEO's wordsThe CEOCompany confidentiality, if taken from diligence
6A dated event, such as a system retirementThe CEO or a public announcementIf the CEO raises itThe CEOCompany confidentiality, if learned through information rights
7Board figures: revenue, churn, pipelineThe co-investor's board seatNeverNot yours to clearCompany confidentiality
8The co-investor's diligence memo or data roomThe co-investorNeverNot yours to clearCompany confidentiality and discretion between investors
9The co-investor's view of the company or CEOThe co-investorNeverNot yours to clearDiscretion between investors
10Who holds shares, and on what termsThe cap tableNot needed; leave it outThe co-investorDiscretion between investors
11SourceX's stage updates on your referralSourceXStays inside your fundSourceX, in writingPartner agreement 4.1 and 4.6
12Any reward estimateYour partner dashboardStays inside your fund; never to the companyNobodyPartner agreement 4.6; it also exposes the payout

Three of the rows deserve a line each. Row 5 is metadata, not records: what kind, roughly how much, over how many years, in which system, owned by whom. Files, samples and logins never travel, whoever offers them. Row 11 exists because terms section 7 already keeps other partners' records from you, and the partner agreement keeps SourceX's updates inside your firm and the advisers bound to it. Row 12 matters twice over: the partner agreement forbids telling a company that an estimate or interest assures a purchase or a reward (4.6), and the terms call portal estimates projections, not promises.

Method. The twelve facts are the ones a co-investing fund commonly holds; each was tagged by origin and checked on 2026-10-27 against SourceX's partner agreement (sections 1.6, 4, 5.3 and 7.8), the program terms (sections 7 to 9), the screening guidance and the NVCA model agreement as excerpted. The checklist cannot read your own documents. A side letter or information-rights clause can be stricter or looser, and that document governs. For the professional rules that bind accountants, lawyers and advisers when they mention a client's name, see what to share under a referral confidentiality clause.

One introducer whose standing does not lean on the co-investor's file

The person who introduces should be someone whose own relationship with the CEO lets them ask without quoting anything learned in confidence. If your fund's only warm route to the CEO runs through the co-investor, then the co-investor asks or declines, and a decline ends it.

Ask the co-investor first, in plain words: "May I raise a SourceX introduction with your CEO myself, using only public facts and the program's fit tests, and mentioning nothing you have told me?" A yes in writing covers the discretion between you. It does not release the co-investor's duty to the company, and it does not replace the CEO's own yes. One sender, one message, public facts only: the CEO hears the program described, decides, and tells you about her company in her own words if she wants to go ahead. The duplicate-claim checklist helps you confirm nobody else has already introduced her.

Progress reports and rewards inside the confidentiality lines

Progress. SourceX gives a partner what it reasonably needs to follow its own referral and reward, as generic stages or reference codes (4.6). Those updates stay inside your fund. The co-investor hears how things are going from the CEO, if the CEO chooses to tell her investors, never from you. Agree on that before the first message so nobody feels shut out later.

Rewards. One partner is credited per company. The reward is the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap, paid separately by SourceX and never deducted from the company's compensation. Illustrative only: an Actual Supplier Payout of $400,000 would mean a $70,000 reward to the credited partner and nothing to the co-investor. If the co-investor helped and your firms want to recognize it, that is an arrangement between the funds, outside the program, and both firms' rules apply. Keep figures out of it with the company: because the reward tracks the payout, quoting one discloses the other, and the payout is a non-public deal detail.

A board observer's aside and an associate's draft (Illustrative)

Illustrative: Fund A and Fund B co-invested in a 190-person medical equipment service company that keeps fourteen years of service tickets and repair logs it created itself. Fund B holds a board observer seat. On a syndicate call, Fund B's partner mentions that the latest board pack plans to retire the company's field service system next spring. A Fund A associate drafts a note to SourceX the same afternoon.

Line in the first draftOriginChecklist verdictWhat replaced it
"Fourteen years of service and repair records"Fund B, from the board packRow 5 via origin 4: stays behindNothing, until the CEO described the records herself
"Retiring its field service system next spring"Fund B, from the board packRow 6 via origin 4: stays behindThe CEO raised the retirement on her own call with Fund A
The CEO's direct email addressFund B's syndicate threadRow 2: discretion between investorsThe card the CEO gave a Fund A partner at an industry event
"Revenue has doubled since the round"Fund B, from board figuresRow 7: neverDeleted

What happened next: Fund A asked Fund B first. Fund B agreed that Fund A could approach the CEO, provided nothing from the board pack was mentioned. The Fund A partner who knew the CEO wrote to her with public facts and the fit tests only. She said yes in writing and, on the call that followed, described the record history and the planned system retirement herself. With her agreement, those two facts went into the introduction as her words. Fund B learned that a conversation had started when the CEO told her board.

Limits of a fact-by-fact test

  • Your documents govern, not a model. The NVCA form is a template. A co-investor's actual agreement, and your own fund's side letters, may draw the lines elsewhere.
  • Origins blur. A fact the CEO told you may also sit in the board pack. When unsure, ask the CEO to state it in writing and quote that.
  • The CEO cannot release everything. She can clear the company's facts, not the co-investor's own confidences, such as its opinion of the company.
  • The company's own duties are a separate question. Whether the company can license its records without breaking promises it made to its own customers or staff is part of SourceX's screening and rights review, not something any investor settles.
  • Shared tools leak. Syndicate CRMs and shared notes can carry confidential facts into a draft without anyone noticing. Draft introductions outside them.
  • A clean introduction promises nothing. Requirements vary with SourceX's current data needs and are checked in review; a confidentiality-perfect introduction can still end without a license.

Next step

Refer a company. No cap on rewards. Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

Run the twelve rows over your draft, ask the co-investor before you lean on anything it told you, and let the CEO's own words carry the facts; then register as a partner, test the company against who qualifies and read the confidentiality and attribution sections of the program terms. The main site's comparison of license confidentiality and training data disclosure covers what stays confidential once a license is signed, and the overview for venture platform teams sets out the fund-side program.

Keeping a co-investor's confidence is a referral question; judging SourceX as a possible investment is a different one, and readers weighing it can request materials through the SourceX investor overview.

This article is for information only and is not an offer to sell or a solicitation of an offer to buy securities. Any offering by SourceX is made only to verified accredited investors through its offering documents.

  1. Step 1Share your linkSend your personal link to a company you know.
  2. Step 2Company appliesThe company applies itself at /apply.
  3. Step 3Company signs and is paidThe company signs, delivers its data and is paid by SourceX under its agreement.
  4. Step 4You get your rewardthe greater of $50,000 plus 5% and 15% of the actual supplier payout, with no cap. A reward becomes payable after SourceX has paid the referred company under its signed agreement and the payout conditions in the program terms are met, including finance approval and your tax and payment details.

Common questions

If the CEO agrees to the introduction, does that release what a co-investor told me?

Not by itself. The CEO can clear the company's own facts for SourceX, ideally by stating them to you directly, but the co-investor's promise lives in the co-investor's own documents and its confidences about its own views are not the CEO's to release. Ask the co-investor too, and when in doubt use only what the CEO tells you.

Can I tell a co-investor how my SourceX referral is progressing?

SourceX's updates are confidential information under the partner agreement, which limits who may receive them to your own employees, advisers and service providers. The co-investor is not on that list. If the CEO chooses to tell her investors where things stand, that is her call.

Is a company fact I found on its own website safe to include?

Usually, provided it really is public and you did not first learn it from a board pack. When a fact appears both publicly and in confidential materials, cite the public source in your note, or better, use the CEO's own words.

Sources

  1. refer.sourcex.si/terms
  2. sourcex.si/documents/partner/SourceX_Channel_Partner_Ag…
  3. refer.sourcex.si/who-qualifies
  4. nvca.org/wp-content/uploads/2019/06/NVCA-Model-Docume…
  5. sourcex.si/investors

Free resources

Know a company with valuable proprietary data?

Become a referral partner, get your link and introduce the company’s CEO (in an owner-run company, usually the owner). Referral partners can join from most countries. We can't work with partners in countries or regions under U.S. sanctions or on U.S. restricted-party lists. The companies you introduce should be based in the U.S., Canada and the EU, or in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia with at least 70% of their data in English.

Refer a company →

I own a business

Explore licensing your company's data directly to SourceX for AI training and evaluation. Start a short assessment; no uploads needed.

Start an assessment